Abbott Laboratories (ABT) Short-term Investments (2009 - 2026)

Abbott Laboratories has disclosed Short-term Investments across 18 years of filings, most recently posting $492.0 million for Q1 2026.

• Short-term Investments for Q1 2026 came in at $492.0 million, up 57.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $492.0 million (up 57.69% YoY), and the FY2025 annual result was $417.0 million, up 18.8% from the prior year.
• Short-term Investments came in at $492.0 million for Q1 2026 at Abbott Laboratories, up from $417.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $492.0 million in Q1 2026 to a low of $222.0 million in Q3 2025.
• The 5-year median for Short-term Investments is $338.0 million (2023), against an average of $341.4 million.
• Across the five-year window, Short-term Investments sank 36.0% in 2022 and surged 57.69% in 2026, its largest moves.
• Abbott Laboratories' Short-term Investments stood at $288.0 million in 2022, then soared by 32.99% to $383.0 million in 2023, then retreated by 8.36% to $351.0 million in 2024, then increased by 18.8% to $417.0 million in 2025, then climbed by 17.99% to $492.0 million in 2026.
• The last three Short-term Investments figures came in at $492.0 million (Q1 2026), $417.0 million (Q4 2025), and $222.0 million (Q3 2025), per Business Quant data.